C12Y 301/13004
Poly-specific ribonuclease
Official title: Poly(A)-specific ribonuclease (3.1.13.4)
C12Y301/13004 (Poly-specific ribonuclease) appears on 1 US grants and 9 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 9
- Assignees
- 9
- Inventors
- 18
- Latest grant
- 11 Jan 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Fusion proteins for improved gene editing24 Sep 2026US 2026/0286397 A1New York Genome Center, Inc.
- Systems and methods for modulating rna11 Sep 2025US 2025/0283062 A1The University of Chicago
- Compositions for rna-protein tethering and methods of using13 Feb 2025US 2025/0051788 A1Donald Danforth Plant Science Center
- Parn as a biomarker and therapeutic target26 Dec 2024US 2024/0425866 A1The Regents of the University of Colorado, a body corporate
- Modulators of telomere disease14 Jul 2022US 2022/0220479 A1Children's Medical Center Corporation
Most cited
By later US patents